Compare SRRK & AIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRRK | AIR |
|---|---|---|
| Founded | 2012 | 1951 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 5.8B |
| IPO Year | 2018 | 1994 |
| Metric | SRRK | AIR |
|---|---|---|
| Price | $43.58 | $104.07 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 7 |
| Target Price | $70.44 | ★ $154.50 |
| AVG Volume (30 Days) | ★ 2.2M | 514.4K |
| Earning Date | 11-13-2026 | 09-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1288.57 |
| EPS | N/A | ★ 1.00 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $11.56 |
| Revenue Next Year | $1,978.85 | $6.80 |
| P/E Ratio | ★ N/A | $102.70 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $27.07 | $76.10 |
| 52 Week High | $61.76 | $154.00 |
| Indicator | SRRK | AIR |
|---|---|---|
| Relative Strength Index (RSI) | 30.08 | 33.24 |
| Support Level | $41.51 | $101.48 |
| Resistance Level | $50.09 | $121.24 |
| Average True Range (ATR) | 2.34 | 5.49 |
| MACD | -0.63 | -1.02 |
| Stochastic Oscillator | 13.26 | 20.95 |
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
AAR Corp offers a broad line of products and services to commercial and government aerospace customers and operates internationally. It is a diversified provider of services and products to the commercial aviation and government and defense markets, serving aircraft fleet operators, original equipment manufacturers, independent service providers, and domestic and foreign military customers. It operates through the Parts Supply, Repair, Engineering and Software, Government Solutions, and Legacy Commercial Programs segments. The Parts Supply segment mainly consists of new parts distribution and sales of used serviceable material, including aircraft, engine, and airframe parts and components (USM), and generates the maximum revenue. It generates the maximum revenue from North America.